Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-06

Clinical Trial Update: Isothiocyanates and Metabolic Health [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial update on isothiocyanates for metabolic disturbances; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isothiocyanates

Snippet

Sponsor: The Swedish School of Sport and Health Sciences | Conditions: Metabolic Disturbance | Phase 1, Phase 2 | Status: UNKNOWN